Thank you for taking the time to help us out with this feasibility study. Your input will be invaluable. Please complete all applicable questions fully and ensure you complete the questionnaire to make sure you are entered in the prize draw to have a chance of winning one of four £100 Amazon vouchers.
Please note we are focused on responses from patients suffering with Chemotherapy-induced peripheral neuropathy. If this condition does not affect you, we will not consider your answers.
Chemotherapy-induced peripheral neuropathy (CIPN) is a progressive, enduring, and often irreversible condition featuring pain, numbness, tingling and sensitivity to cold in the hands and feet (sometimes progressing to the arms and legs) that afflicts between 30% and 40% of patients undergoing chemotherapy.
By completing this survey you agree to allow us to use your data to determine if a study including patients with CIPN can be run in the United Kingdom. Your identifying data will not be shared with any third party without your consent.